![Chidozie Ugwumba](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chidozie Ugwumba
Fondateur chez
Symbiosis Capital Management LLC
Fortune : 256 716 $ au 31/08/2026
Profil
Mr. Chidozie K.
Ugwumba, CFA MBA, is a Founder & Managing Partner at Symbiosis Capital Management LLC.
He is on the Board of Directors at Rainier Acquisition Corp., CTx Operations, Inc., Clene Nanomedicine, Inc. and Micronoma, Inc. Mr. Ugwumba was previously employed as an Independent Director by Carisma Therapeutics, Inc., an Independent Director by Clene, Inc., a Board Member by Maat Pharma SA, a Managing Director by WIT LLC, an Assistant Vice President by Partners Group (USA), Inc., an Analyst by NEUBERGER BERMAN LLC, and a Co-Founder by Hunting Hill Global Capital LLC.
He also served on the board at Platelet BioGenesis, Inc. He received his undergraduate degree from Amherst College, an MBA from Cornell University and an MBA from Johnson Graduate School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
1,16 % | 27/08/2026 | 25 000 ( 1,16 % ) | 254 500 $ | 31/08/2026 |
| 31/05/2025 | 2 215 877 ( 5,3 % ) | 2 216 $ | 31/08/2026 |
Postes actifs de Chidozie Ugwumba
| Sociétés | Poste | Début |
|---|---|---|
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Directeur/Membre du Conseil | 01/12/2020 |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Directeur/Membre du Conseil | - |
Symbiosis Capital Management LLC
 Symbiosis Capital Management LLC Investment ManagersFinance SymBiosis invests in both public and private companies located in the united States. The firm targets companies operating in the fields of the biotechnology. It provides financing for seed, early and later stage capital requirements. | Fondateur | - |
Micronoma, Inc.
 Micronoma, Inc. Medical/Nursing ServicesHealth Services Operates as cancer diagnostic company | Directeur/Membre du Conseil | - |
Anciens postes connus de Chidozie Ugwumba
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2024 |
| CLENE INC. | Directeur/Membre du Conseil | 15/02/2023 |
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology to produce independent human platelets from human induced pluripotent stem cells | Directeur/Membre du Conseil | 31/12/2022 |
WIT LLC
 WIT LLC Investment ManagersFinance Profile Unavailable. | Director of Investments | 01/01/2021 |
| MAAT PHARMA | Directeur/Membre du Conseil | 01/01/2021 |
Formation de Chidozie Ugwumba
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Neuberger Berman BD LLC
 Neuberger Berman BD LLC Investment ManagersFinance NBBD-IM offers clients investment solutions across asset classes, styles, capitalizations and geographies in both public and private markets, as well as multi-asset class solutions that bring them all together. For equity investments, the firm tends to focus on stocks with solid balance sheets, relatively low price-to-earnings ratios, low price-to-cash flow ratios, strong cash flows, above-average yields, sustainable earnings growth, reasonable valuation multiples relative to growth prospects, sound franchise values and significant insider ownership. They use both top-down and bottom-up analysis to select investments. In addition, the firm uses options and futures and occasionally invests in ADRs and private equity opportunities. | Finance |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hunting Hill Global Capital LLC
 Hunting Hill Global Capital LLC Investment ManagersFinance Hunting Hill aims to provide attractive risk-adjusted absolute returns over the course of a full business cycle. Their Funds’ investment strategy seeks to capitalize on trading opportunities in a range of situations where idiosyncratic events—macroeconomic shocks, monetary/fiscal policy decisions, regulatory activity, corporate actions, or other sources of volatility— have disrupted intrinsic relationships between security prices. | Finance |
WIT LLC
WIT LLC Investment ManagersFinance Profile Unavailable. | Finance |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology to produce independent human platelets from human induced pluripotent stem cells | Commercial Services |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Health Technology |
Partners Group Inc (United States)
 Partners Group Inc (United States) Investment ManagersFinance Partners Group invests in companies located across the globe. the firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. It also acts as a co-investor. | Finance |
Micronoma, Inc.
Micronoma, Inc. Medical/Nursing ServicesHealth Services Operates as cancer diagnostic company | Health Services |
Clene, Inc.
 Clene, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Symbiosis Capital Management LLC
Symbiosis Capital Management LLC Investment ManagersFinance SymBiosis invests in both public and private companies located in the united States. The firm targets companies operating in the fields of the biotechnology. It provides financing for seed, early and later stage capital requirements. | Finance |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
